Àrùn jẹjẹrẹ ọmú ni àrùn jẹjẹrẹ tí ó wọ́pọ̀ jùlọ láàrín àwọn obìnrin kárí ayé, pẹ̀lú iye tí wọ́n fojú bù pé ó tó mílíọ̀nù 2.3 àwọn àìsàn tuntun tí wọ́n ṣàwárí ní ọdún 2020, gẹ́gẹ́ bí àjọ ìlera àgbáyé (WHO) ṣe sọ. Ìṣẹ̀lẹ̀ àti bí àrùn jẹjẹrẹ ọmú ṣe wọ́pọ̀ ṣe yàtọ̀ síra ní agbègbè kọ̀ọ̀kan, ṣùgbọ́n ó jẹ́ ìṣòro ìlera tó ṣe pàtàkì kárí ayé.
Ní Orílẹ̀-èdè Amẹ́ríkà, àrùn jẹjẹrẹ ọmú ni àrùn jẹjẹrẹ kejì tí ó wọ́pọ̀ jùlọ láàrín àwọn obìnrin, pẹ̀lú iye tí wọ́n rò pé ó tó 281,5500 àwọn àìsàn tuntun tí wọ́n máa ṣàwárí ní ọdún 2021, gẹ́gẹ́ bí àjọ American Cancer Society ṣe sọ.
Ó ṣeé ṣe kí obìnrin kan ní àrùn jẹjẹrẹ ọmú ní gbogbo ìgbésí ayé rẹ̀, ó sì máa ń tó 1 nínú 8, ìyẹn nǹkan bí 12.9%. Àmọ́ ṣá o, ó ṣe pàtàkì láti kíyè sí i pé ìwọ̀nba ni iye yìí, ó sì lè yàtọ̀ síra ní ìbámu pẹ̀lú àwọn nǹkan bíi ọjọ́ orí, àbùdá, ọ̀nà ìgbésí ayé, àti àyíká.
Zhang ML, Huang ZZ, Zheng Y: [Estimates and prediction on incidence, mortality and prevalence of breast cancer in China, 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (10): 1049-51.
Peng J, Ganry O, Tramier B, Dubreuil A, Raverdy N, Thulliez A: [Incidence and prevalence estimations for breast and colorectal cancer in the Picardy region]. Rev Epidemiol Sante Publique. 2002, 50 (5): 427-32.
Liu FC, Lin HT, Kuo CF, See LC, Chiou MJ, Yu HP: Epidemiology and survival outcome of breast cancer in a nationwide study. Oncotarget. 2017, 8 (10): 16939-16950.
Asadzadeh Vostakolaei F, Broeders MJ, Mousavi SM, Kiemeney LA, Verbeek AL: The effect of demographic and lifestyle changes on the burden of breast cancer in Iranian women: a projection to 2030. Breast. 2013, 22 (3): 277-81.
Runco R, Laganà S, Marino G, Di Grazia A, Marino L, Umina V, Girlando A, Ricottone N, D'Agostino A, Marletta F, Tamburo M, Corsaro G, Rallo F, Santacaterina A, Acquaviva G, Crispi M, Palazzolo C, Platania A, Spatola C, Privitera G, Frosina P, Garufi G, Bonanno S, Rosso A, Barone V, Corallo A, Sansotta G, Delia P, Donato V, Lopes S, Pisana M, Borzì F, Iatì G, Potami A, Messina G, Parisi S, Frosina L, Marletta D, De Renzis C, Pontoriero A, Pergolizzi S: Breast cancer bone metastases: an epidemiologic study in selected radiation departments. Tumori. , 100 (1): 38-41.
Ìyàsímímọ́: ìtọ́jú ìlera
Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.
A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.
Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.
Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.
Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.
Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.
A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).
DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;
(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;
ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.
Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.
Ìfọ̀rọ̀wérọ̀
Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.
How common is breast cancer?
Breast cancer is the most common cancer among women worldwide, with an estimated 2.3 million new cases diagnosed in 2020, according to the World Health Organization (WHO). The incidence and prevalence of breast cancer vary by region, but it is a significant health concern globally.
In the United States, breast cancer is the second most common cancer among women, with an estimated 281,5500 new cases expected to be diagnosed in 2021, according to the American Cancer Society.
The lifetime risk of a woman developing breast cancer is approximately 1 in 8, or about 12.9%. However, it is important to note that these numbers are estimates and may vary based on factors such as age, genetics, lifestyle, and environmental factors.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ní nǹkan bí
BioMedLib nlo awọn kọnputa adaṣe (awọn alugoridimu ẹkọ ẹrọ) lati ṣe agbejade awọn tọkọtaya ibeere ati idahun.
A bẹrẹ pẹlu awọn atẹjade biomedical miliọnu 35 ti PubMed/Medline. Pẹlupẹlu, awọn oju-iwe wẹẹbu ti RefinedWeb.
